JENNA LOEHMANN: Open Payments
NPI 1407303225 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 27 payments from 9 companies in 2025. Trend: 2023 $1,639 · 2024 $752 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $374 |
| Xeris Pharmaceuticals, Inc. | 7 | $231 |
| Novo Nordisk Inc | 8 | $190 |
| CeQur Corporation | 1 | $136 |
| Amgen Inc. | 1 | $125 |
| Corcept Therapeutics | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $100 |
| BETA BIONICS, INC. | 1 | $84 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
Products named: FREESTYLE LIBRE 3, GVOKE HYPOPEN, Ozempic, CeQur Simplicity, TEPEZZA, Korlym, REZDIFFRA, iLet Bionic Pancreas.
Industry payments across FL — which companies pay providers there.
